View Financial HealthCreotech Instruments 배당 및 자사주 매입배당 기준 점검 2/6Creotech Instruments 은(는) 현재 수익률이 32.41% 인 배당금 지급 회사입니다.핵심 정보32.4%배당 수익률0%자사주 매입 수익률총 주주 수익률0%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jun 11Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million.Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million. Security Name: Series M Ordinary Bearer Shares Security Type: Common Stock Securities Offered: 650,000 Price\Range: €740 Transaction Features: Regulation S; Subsequent Direct ListingReported Earnings • Jun 04First quarter 2026 earnings released: zł2.95 loss per share (vs zł0.59 profit in 1Q 2025)First quarter 2026 results: zł2.95 loss per share (down from zł0.59 profit in 1Q 2025). Revenue: zł18.0m (down 30% from 1Q 2025). Net loss: zł8.41m (down zł9.82m from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).공시 • May 08Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026, at 14:00 Central European Standard Time.공시 • Apr 04Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A.Creotech Instruments S.A. (WSE:CRI) agreed to Spin-Off Quantum segments on April 17, 2025. As part of the spinoff, Creotech Instruments shareholders will be allocated shares in the new quantum company in proportion to their holdings. The allocation of shares will take place through a public offering of shares. The quantum company is expected to go public on the WSE, at the same time, a new company will be created to focus on the development and commercialization of quantum systems so far developed at Creotech and assuming the prospectus procedure before Poland's financial market regulator KNF and the receival of all corporate approvals proceeds without delay and the spinoff proposal receives the approval of the shareholders. The estimated date for concluding the spinoff is late 2025/early 2026. Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A. on April 2, 2026. Final record date for entitlement to the distribution is April 2, 2026. Creotech Quantum debut on WSE scheduled for April 17, 2026.공시 • Aug 25Creotech Instruments S.A. to Report First Half, 2025 Results on Sep 26, 2025Creotech Instruments S.A. announced that they will report first half, 2025 results on Sep 26, 2025공시 • May 19Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025.Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.33m (down 11% from 2Q 2023). Net loss: zł4.22m (loss widened 17% from 2Q 2023).New Risk • Sep 30New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €89.1m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 92% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (€89.1m market cap, or US$99.2m).New Risk • Aug 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).공시 • May 21Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024.New Risk • Mar 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Feb 13New major risk - Revenue and earnings growthRevenue has declined by 8.5% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).공시 • Feb 02+ 3 more updatesCreotech Instruments S.A. to Report First Half, 2024 Results on Sep 27, 2024Creotech Instruments S.A. announced that they will report first half, 2024 results on Sep 27, 2024New Risk • Dec 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Oct 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (€89.3m market cap, or US$94.8m).공시 • Jun 04Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023, at 10:00 Central European Standard Time.공시 • Feb 03+ 2 more updatesCreotech Instruments S.A. to Report Q3, 2023 Results on Nov 27, 2023Creotech Instruments S.A. announced that they will report Q3, 2023 results on Nov 27, 2023Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł4.91m (down 26% from 3Q 2021). Net loss: zł2.24m (down 451% from profit in 3Q 2021).Reported Earnings • Oct 04Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł2.59m (down 61% from 2Q 2021). Net loss: zł2.93m (down zł3.57m from profit in 2Q 2021).공시 • Jul 26Creotech Instruments S.A. to Report Q2, 2023 Results on Sep 28, 2022Creotech Instruments S.A. announced that they will report Q2, 2023 results on Sep 28, 2022공시 • Jun 07Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022, at 14:00 Central European Standard Time.공시 • Jan 30+ 4 more updatesCreotech Instruments S.A. to Report Q1, 2022 Results on May 16, 2022Creotech Instruments S.A. announced that they will report Q1, 2022 results on May 16, 2022지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 5OB 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 5OB 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Creotech Instruments 배당 수익률 vs 시장5OB의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (5OB)32.4%시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.7%업계 평균 (Aerospace & Defense)0.9%분석가 예측 (5OB) (최대 3년)n/a주목할만한 배당금: 5OB 의 배당금( 32.41% )은 German 시장에서 배당금 지급자의 하위 25%( 1.49% )보다 높습니다.고배당: 5OB 의 배당금( 32.41% )은 German 시장( 4.68% )주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 5OB 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 5OB 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/16 00:01종가2026/06/16 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Creotech Instruments S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jun 11Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million.Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million. Security Name: Series M Ordinary Bearer Shares Security Type: Common Stock Securities Offered: 650,000 Price\Range: €740 Transaction Features: Regulation S; Subsequent Direct Listing
Reported Earnings • Jun 04First quarter 2026 earnings released: zł2.95 loss per share (vs zł0.59 profit in 1Q 2025)First quarter 2026 results: zł2.95 loss per share (down from zł0.59 profit in 1Q 2025). Revenue: zł18.0m (down 30% from 1Q 2025). Net loss: zł8.41m (down zł9.82m from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).
공시 • May 08Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026, at 14:00 Central European Standard Time.
공시 • Apr 04Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A.Creotech Instruments S.A. (WSE:CRI) agreed to Spin-Off Quantum segments on April 17, 2025. As part of the spinoff, Creotech Instruments shareholders will be allocated shares in the new quantum company in proportion to their holdings. The allocation of shares will take place through a public offering of shares. The quantum company is expected to go public on the WSE, at the same time, a new company will be created to focus on the development and commercialization of quantum systems so far developed at Creotech and assuming the prospectus procedure before Poland's financial market regulator KNF and the receival of all corporate approvals proceeds without delay and the spinoff proposal receives the approval of the shareholders. The estimated date for concluding the spinoff is late 2025/early 2026. Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A. on April 2, 2026. Final record date for entitlement to the distribution is April 2, 2026. Creotech Quantum debut on WSE scheduled for April 17, 2026.
공시 • Aug 25Creotech Instruments S.A. to Report First Half, 2025 Results on Sep 26, 2025Creotech Instruments S.A. announced that they will report first half, 2025 results on Sep 26, 2025
공시 • May 19Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025.
Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.33m (down 11% from 2Q 2023). Net loss: zł4.22m (loss widened 17% from 2Q 2023).
New Risk • Sep 30New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €89.1m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 92% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (€89.1m market cap, or US$99.2m).
New Risk • Aug 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
공시 • May 21Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024.
New Risk • Mar 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Feb 13New major risk - Revenue and earnings growthRevenue has declined by 8.5% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).
공시 • Feb 02+ 3 more updatesCreotech Instruments S.A. to Report First Half, 2024 Results on Sep 27, 2024Creotech Instruments S.A. announced that they will report first half, 2024 results on Sep 27, 2024
New Risk • Dec 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Oct 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (€89.3m market cap, or US$94.8m).
공시 • Jun 04Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023, at 10:00 Central European Standard Time.
공시 • Feb 03+ 2 more updatesCreotech Instruments S.A. to Report Q3, 2023 Results on Nov 27, 2023Creotech Instruments S.A. announced that they will report Q3, 2023 results on Nov 27, 2023
Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł4.91m (down 26% from 3Q 2021). Net loss: zł2.24m (down 451% from profit in 3Q 2021).
Reported Earnings • Oct 04Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł2.59m (down 61% from 2Q 2021). Net loss: zł2.93m (down zł3.57m from profit in 2Q 2021).
공시 • Jul 26Creotech Instruments S.A. to Report Q2, 2023 Results on Sep 28, 2022Creotech Instruments S.A. announced that they will report Q2, 2023 results on Sep 28, 2022
공시 • Jun 07Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022, at 14:00 Central European Standard Time.
공시 • Jan 30+ 4 more updatesCreotech Instruments S.A. to Report Q1, 2022 Results on May 16, 2022Creotech Instruments S.A. announced that they will report Q1, 2022 results on May 16, 2022